• Trachoma is a bacterial infection of the eye that can cause complications including blindness.
  • This communicable disease still occurs in many outback Aboriginal communities.
  • Treatment includes antibiotics to kill the infection, surgery to correct eyelid deformities and health promotion and environmental health to promote clean faces.

About trachoma

Trachoma is a bacterial infection of the eye that can cause complications including blindness. It is caused by Chlamydia trachomatis. This preventable disease is linked to poor hygiene and is often associated with poverty. Lack of facial cleanliness is the main factor that allows the spread of the infection. Trachoma is also sometimes known as sandy blight.

This communicable disease is still common in many remote Aboriginal communities. More than 40 developing countries throughout Africa and Asia are also affected by trachoma, particularly in rural areas where hygiene tends to be poor.

During the 20th century, there was considerable improvement in living conditions around the world. Separate rooms for sleeping, running water and plumbed sewerage meant that trachoma disappeared from all developed countries – except Australia.

Australia is the only Western nation still affected by trachoma. In 2009, the Australian Government made a commitment to eliminate blinding trachoma from Australian Aboriginal communities by 2020.

How trachoma is spread

Trachoma is a communicable disease caused by the bacterium Chlamydia trachomatis. It is usually transmitted by:

  • direct contact such as touching infected eye secretions
  • other forms of direct contact such as touching infected nasal secretions
  • indirect contact such as touching contaminated items – for example, towels, sheets, blankets or clothing.

A single episode of chlamydial conjunctivitis, inclusion conjunctivitis, will resolve spontaneously over a month or two and leave little or no impact. An individual may need to have around 150 episodes of reinfection to sustain the intense inflammation for sufficiently long to lead to severe scarring that leads to trichiasis and blindness.

Symptoms of trachoma

Signs and symptoms begin within five to 12 days following infection and may include:

  • eye irritation, redness and discharge (conjunctivitis)
  • swelling of the eyelids
  • inflammation inside the upper eyelid and lymphoid follicles (lumps caused by an immune system reaction)
  • scarring and distortion of the upper eyelid develops over time from repeated episodes of reinfection
  • development of eyelashes that turn into the upper lid and then rub on the cornea
  • abnormal growth of corneal blood vessels
  • cornea scarring (transparent membrane that covers the eye surface).

People with trachoma may not experience symptoms (asymptomatic) and the condition may go unrecognised, unless it’s specifically looked for.

Complications of trachoma

Without medical treatment, recurrent infections and inflammation can cause corneal scarring and eyelid deformities. A common late complication is eyelid inversion (entropion) – the lashes turn inwards (trichiasis) and continually rub against the cornea. This irritation can cause vision loss and blindness in the long term.

The incidence of trachoma is high among Aboriginal populations

Trachoma remains rife in many remote Aboriginal communities in Australia. Depending on the area, community disease rates range from less than 5% to more than 20%.

Risk factors of trachoma

Trachoma is linked to poor personal and community hygiene, and is often associated with poverty.

Particular risk factors include:

  • inadequate personal hygiene, especially a dirty face
  • lack of understanding about the importance of environmental cleanliness and personal hygiene, especially about facial cleanliness in children
  • inadequate housing and the lack of functional bathrooms
  • crowded living conditions, such as having children share the same bed
  • poor water supply (about one Aboriginal person in six doesn’t have a drinkable water supply in the Northern Territory)
  • living inland, since coastal populations can clean themselves by swimming in the sea
  • young age, since the infection is more common among preschool children.

Diagnosis of trachoma

Tests used to diagnose trachoma may include:

  • medical history
  • physical examination including an eye examination (including everting or flipping the eyelid)
  • eye swab for laboratory testing, but the diagnosis is normally made by clinical examination.

Treatment for trachoma

Treatment depends on the severity of the condition, but may include:

  • antibiotic medications – a single oral dose of an antibiotic (azithromycin) is the first line of treatment in uncomplicated cases. This medication kills off the bacteria so that the body’s natural healing processes can repair the eye. Antibiotics must be given to all household members where trachoma is found. In areas where there is widespread infection, the whole community may need to be treated. Treatment may need to be repeated every six to 12 months.
  • surgery – this is used to correct the eyelid deformity and evert (turn outwards) the injured eyelashes in older people.

Prevention of trachoma

A clean face and clean environment are the main prevention strategies to combat trachoma (no visible secretions from the eyes or nose). The Australian guidelines (prepared by Communicable Disease Network Australia) closely follow those outlined in SAFE, the World Health Organization’s proposed form of trachoma control. SAFE stands for Surgery, Antibiotics, Facial cleanliness and Environmental improvement.

Prevention of trachoma in remote communities is proving to be difficult. During the 1970s, the Australian Government treated nearly 40,000 Australians affected with trachoma. In November 2006, the National Trachoma Surveillance and Reporting Unit (NTSRU) was established to combat trachoma among remote Aboriginal communities.

The proper implementation of the full SAFE Strategy has significantly reduced trachoma in many communities. The overall prevalence of trachoma in children between five and nine years old in endemic areas in 2009 was 14% and, in 2018, this had been reduced to 4%. However, according to the NTRSU, 12% of communities had rates over 20%.

Where to get help


More information


The following content is displayed as Tabs. Once you have activated a link navigate to the end of the list to view its associated content. The activated link is defined as Active Tab

Eye conditions

Content Partner

This page has been produced in consultation with and approved by: Royal Australian New Zealand College of Ophthalmologists (RANZCO)

Last updated: August 2020

Content on this website is provided for information purposes only. Information about a therapy, service, product or treatment does not in any way endorse or support such therapy, service, product or treatment and is not intended to replace advice from your doctor or other registered health professional. The information and materials contained on this website are not intended to constitute a comprehensive guide concerning all aspects of the therapy, product or treatment described on the website. All users are urged to always seek advice from a registered health care professional for diagnosis and answers to their medical questions and to ascertain whether the particular therapy, service, product or treatment described on the website is suitable in their circumstances. The State of Victoria and the Department of Health & Human Services shall not bear any liability for reliance by any user on the materials contained on this website.